ArticleCureus2025
Cord Blood Bilirubin, Albumin, and Hemoglobin as Predictors of Significant Hyperbilirubinemia in ABO-Incompatible Newborns: A Prospective Study in a Tertiary Neonatal Center in India.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aim ABO incompatibility is a common cause of neonatal hyperbilirubinemia. Early identification of babies at risk of neonatal jaundice allows timely treatment and helps minimize the risk of kernicterus. Given the paucity of data on Indian neonates with ABO incompatibility, this study aimed to identify reliable cord blood predictors of early hyperbilirubinemia by evaluating umbilical cord bilirubin, albumin, and hemoglobin levels in ABO-incompatible newborns. Methods This study was conducted at a tertiary care hospital in India and included 210 babies with blood groups A+ve, B+ve, or AB+ve born to mothers with blood group O+ve. All included neonates had a gestational age >37 weeks and a birth weight between 2.5 and 4 kg. Cord blood bilirubin, albumin, hemoglobin, and blood grouping and typing were evaluated at birth. Newborns were monitored for jaundice until the fifth postnatal day and further assessed by measuring total, direct, and indirect bilirubin levels. Results Of the 210 babies studied, 156 (74.28%) developed jaundice requiring phototherapy, 19 (9%) developed jaundice but did not require phototherapy, and 35 (16.7%) did not develop jaundice. The mean cord bilirubin level (2.8 mg/dl) was higher, while mean cord albumin (2.64 g/dl) and hemoglobin (14.41 g/dl) levels were lower among newborns who developed jaundice requiring phototherapy compared with those who did not. Babies with cord bilirubin >2.3 mg/dl, cord hemoglobin <15 g/dl, and cord albumin ≤2.5 g/dl were more likely to develop significant hyperbilirubinemia associated with ABO incompatibility. Conclusions Umbilical cord blood levels of bilirubin, albumin, and hemoglobin demonstrated potential as early predictors of significant hyperbilirubinemia in ABO-incompatible term neonates. Incorporating cord blood screening into routine neonatal care could facilitate early identification and timely intervention, particularly in resource-limited settings. However, further validation is needed before clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.